Example：10.1021/acsami.1c06204 or Chem. Rev., 2007, 107, 2411-2502
Impact of group transdiagnostic cognitive-behavior therapy for anxiety disorders on comorbid diagnoses: Results from a pragmatic randomized clinical trial in primary care Depression and Anxiety (IF6.505), Pub Date : 2021-06-18, DOI: 10.1002/da.23184 Peter J. Norton, Martin D. Provencher, Christopher J. Kilby, Pasquale Roberge
Anxiety and depressive disorders are the most common mental illnesses worldwide, with most individuals meeting criteria for more than one diagnosis. Most cognitive-behavioral therapy (CBT) approaches target only one disorder at a time, resulting in the need to treat comorbid diagnoses sequentially. Transdiagnostic CBT protocols have been developed that simultaneously treat principal and comorbid disorders.